This inventor holds 3 USPTO granted patents. Top assignee: Nisshin Flour Milling Co., Ltd.. Active years: 1997-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-2000
Title: Masato Ariga: Innovator in Biomedical Research
Introduction
Masato Ariga is a notable inventor based in Ohimachi, Japan. He has made significant contributions to biomedical research, particularly in the development of experimental models and pharmaceutical agents. With a total of 3 patents, his work has implications for understanding and treating various diseases.
Latest Patents
One of Masato Ariga's latest patents is the creation of a hairless mouse sensitive to Helicobacter pylori. This mouse, designated NS:Hr/ICR, can be easily infected with H. pylori in its alimentary canal, making it a valuable experimental animal model for studying H. pylori infection. Another significant patent involves agents for inhibiting the production of IL-1.beta. and the release of TNF.alpha. These pharmaceutical agents, derived from 1-cinnamoyl-2-pyrrolidinone derivatives, are useful in treating or preventing diseases such as chronic rheumatism and sepsis.
Career Highlights
Masato Ariga is currently associated with Nisshin Flour Milling Co., Ltd., where he continues to innovate in the field of biomedical research. His work has garnered attention for its potential applications in medical science and therapeutic development.
Collaborations
Throughout his career, Masato has collaborated with esteemed colleagues, including Koichi Katsuyama and Shigeo Hatanaka. These collaborations have further enriched his research and contributed to the advancement of their shared goals in biomedical innovation.
Conclusion
Masato Ariga's contributions to biomedical research through his patents and collaborations highlight his role as a significant inventor in the field. His innovative work continues to pave the way for advancements in understanding and treating critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile